SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-23-024943
Filing Date
2023-03-31
Accepted
2023-03-31 06:16:52
Documents
2
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 3/A  
1 ownership.xml 3/A 3485
2 POWER OF ATTORNEY ea175404ex24-1_cadrenal.htm EX-24.1 6893
  Complete submission text file 0001213900-23-024943.txt   11702
Mailing Address 13 FOX MEADOW RD SCARSDALE NY 10583
Business Address
LOSORDO DOUGLAS W (Reporting) CIK: 0001583810 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-41596 | Film No.: 23783068

Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Issuer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations